Home » Newsletters » BioWorld

BioWorld

Feb. 21, 1996

View Archived Issues

APPOINTMENTS AND ADVANCEMENTS

GENETICS INSTITUTE, AFFYMETRIX EXPAND DNA CHIP AGREEMENT

SEQUANA, GLAXO EXPAND RESEARCH TO INCLUDE OBESITY

INTERNEURON'S CITICOLINE SHOWS BENEFIT IN STROKE PATIENTS

OTHER NEWS TO NOTE

GUILFORD SEEKS TO RAISE $44 MILLION IN PUBLIC OFFERING

FAR-OUT PUFFERFISH SERVES AS GENOMIC PINCH- HITTER FOR FINDING HUMAN

GENENTECH FORMS FIRM TO BOOST DEVELOPMENT OF AIDS VACCINE

CHIRON PAYS $117M FOR NEARLY HALF OF HOECHST'S VACCINE BUSINESS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...